Friedrich Rainer von Coelln

Dr. Friedrich Rainer von Coelln

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2019 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
CBCornelis Blauwendraat
Cornelis Blauwendraat
KHKarl Heilbron
Karl Heilbron
CMCostanza L. Vallerga Msc
Costanza L. Vallerga Msc
SBSara Bandres‐Ciga
Sara Bandres‐Ciga
FCFriedrich Rainer von Coelln
Friedrich Rainer von Coelln
F(for the International Parkinson's Disease Genomics Consortium (IPDGC)
for the International Parkinson's Disease Genomics Consortium (IPDGC)

12 July 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
FCFriedrich Rainer von Coelln
Friedrich Rainer von Coelln
BTBobby Thomas
Bobby Thomas
JSJoseph M. Savitt
Joseph M. Savitt
KLKah Leong Lim
Kah Leong Lim
MSMasayuki Sasaki
Masayuki Sasaki
Ted DawsonTed Dawson
Ted Dawson
Parkinson's disease (PD) is the most common neurodegenerative movement disorder and is characterized pathologically by degeneration of catecholaminergic neurons of the substantia nigra pars compacta and locus coeruleus, among other regions. Autosomal-recessive juvenile Parkinsonism (ARJP) is caused by mutations in the PARK2 gene coding for parkin and constitutes the most common familial form of PD. The majority of ARJP-associated parkin mutations are thought to be loss of function-mutations; however, the pathogenesis of ARJP remains poorly understood. Here, we report the generation of parkin null mice by targeted deletion of parkin exon 7. These mice show a loss of catecholaminergic neurons in the locus coeruleus and an accompanying loss of norepinephrine in discrete regions of the central nervous system. Moreover, there is a dramatic reduction of the norepinephrine-dependent startle response. The nigrostriatal dopaminergic system does not show any impairment. This mouse model will help gain a better understanding of parkin function and the mechanisms underlying parkin-associated PD.

31 August 2005 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
HKHan Seok Ko
Han Seok Ko
FCFriedrich Rainer von Coelln
Friedrich Rainer von Coelln
SSSathya R. Sriram
Sathya R. Sriram
SKSeong Who Kim
Seong Who Kim
KCKenny K. K. Chung
Kenny K. K. Chung
Ted DawsonTed Dawson
Ted Dawson
Autosomal-recessive juvenile parkinsonism (AR-JP) is caused by loss-of-function mutations of the parkin gene. Parkin, a RING-type E3 ubiquitin ligase, is responsible for the ubiquitination and degradation of substrate proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD). Accordingly, the abnormal accumulation of neurotoxic parkin substrates attributable to loss of parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. We evaluated the known parkin substrates identified to date in parkin null mice to determine whether the absence of parkin results in accumulation of these substrates. Here we show that only the aminoacyl-tRNA synthetase cofactor p38 is upregulated in the ventral midbrain/hindbrain of both young and old parkin null mice. Consistent with upregulation in parkin knock-out mice, brains of AR-JP and idiopathic PD and diffuse Lewy body disease also exhibit increased level of p38. In addition, p38 interacts with parkin and parkin ubiquitinates and targets p38 for degradation. Furthermore, overexpression of p38 induces cell death that increases with tumor necrosis factor-α treatment and parkin blocks the pro-cell death effect of p38, whereas the R42P, familial-linked mutant of parkin, fails to rescue cell death. We further show that adenovirus-mediated overexpression of p38 in the substantia nigra in mice leads to loss of dopaminergic neurons. Together, our study represents a major advance in our understanding of parkin function, because it clearly identifies p38 as an important authentic pathophysiologic substrate of parkin. Moreover, these results have important implications for understanding the molecular mechanisms of neurodegeneration in PD.

30 July 2004 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
FCFriedrich Rainer von Coelln
Friedrich Rainer von Coelln
VDValina L. Dawson
Valina L. Dawson
Ted DawsonTed Dawson
Ted Dawson

22 October 1998 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
JSJörg B Schulz
Jörg B Schulz
MWMichael Weller
Michael Weller
RMRussell T Matthews
Russell T Matthews
MHMichael T Heneka
Michael T Heneka
PGPeter Groscurth
Peter Groscurth
TKThomas Klockgether
Thomas Klockgether

24 April 2008 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
FCFriedrich Rainer von Coelln
Friedrich Rainer von Coelln
ARArmin Raible
Armin Raible
TGThomas Gasser
Thomas Gasser
FAFriedrich Asmus
Friedrich Asmus